Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The nuclear receptor coactivator
RAC3
plays important roles in many biological processes and tumorigenesis. We found that
RAC3
is over-expressed in human
chronic myeloid leukemia
cells K562, which are normally resistant to TRAIL-induced apoptosis.
RAC3
down-regulation by siRNA rendered these cells sensitive to TRAIL-induced cell death. In addition to the up-regulation of TRAIL receptors, the process involves Bid, caspases and PARP activation, loss of mitochondrial membrane potential, and release of AIF, cytochrome c and Smac/DIABLO to the cytoplasm. We conclude that
RAC3
is required for TRAIL resistance and that this anti-apoptotic function is independent of its role in hormone receptor signaling.
...
PMID:RAC3 down-regulation sensitizes human chronic myeloid leukemia cells to TRAIL-induced apoptosis. 1792 86
RAC3
belongs to the family of p160 nuclear receptors coactivators and it is over-expressed in several tumors. We have previously shown that
RAC3
is a NF-kappaB coactivator. In this paper, we investigated the role of
RAC3
in cell-sensitivity to apoptosis, using H2O2 in the human embryonic kidney cell line (HEK293), and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) in a human
chronic myeloid leukemia
cell line (K562) naturally resistant to TRAIL. We observed that the tumoral K562 cells have high levels of
RAC3
if compared with the non-tumoral HEK293 cells. The normal or transfected coactivator over-expression inhibits apoptosis through a diminished caspase activity and AIF nuclear translocation, increased NF-kappaB, AKT and p38, and decreased ERK activities. In contrast, inhibition of
RAC3
by siRNA induced sensitivity of K562 to TRAIL-induced apoptosis. Such results suggest that over-expression of
RAC3
contributes to tumor development through molecular mechanisms that do not depend strictly on acetylation and/or steroid hormones, which control cell death. This could be a possible target for future tumor therapies.
...
PMID:[RAC3 nuclear receptor co-activator has a protective role in the apoptosis induced by different stimuli]. 1805 Dec 30